Eric M. Dube, CEO: Travere Therapeutics TVTX Sell · Filed 25/01/23

Trade details

Type: Insider sale
Amount: $208,922.56
Shares · price: 10,736 sh · $19.46 a share
Held after: 351,239 sh
Stock: Travere Therapeutics TVTX
Person: Eric M. DubeCEO
Trade date: 25/01/22
Filed: 25/01/23
Days to filing: 1 days

Sold 3.0% of holdings

Share of holding sold: 3.0%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/23~25/02/21

Eric M. Dube's recent trades

Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.9M
108,493 sh
$6.9M
Filed 09/17
Traded 09/17
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$12.2M
195,841 sh
$12.2M
Filed 09/16
Traded 09/16
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$6.3M
95,666 sh
$6.3M
Filed 09/15
Traded 09/15
Eric M. DubeCEO
Sell10b5-1 planTravere Therapeutics
Sell10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06
Eric M. DubeCEO
Planned sale10b5-1 planTravere Therapeutics
Planned sale10b5-1 plan
Travere Therapeutics
TVTX
$988.9K
22,500 sh
$988.9K
Filed 05/06
Traded 05/06